# Ferring Acquires Gameto for $1.4 Billion to Improve Fertility Treatments

> Ferring Pharmaceuticals buys Gameto for $1.4 billion to make IVF safer and more affordable for women.
- Title: Ferring Acquires Gameto for $1.4 Billion to Improve Fertility…
- Summary: Ferring Pharmaceuticals buys Gameto for $1.4 billion to make IVF safer and more affordable for women. Ferring Pharmaceuticals acquired Gameto for $1.4…
- Keywords: ferring pharmaceuticals, gameto, fertilo, ivf, fertility treatments, fertility drugs, reproductive medicine, cell engineering, egg retrieval, ovarian support cells, Ferring, Acquires
- Source: Inc — https://inc.com/chloe-aiello/this-1-4-billion-deal-aims-to-make-fertility-treatments-safer-and-more-affordable/91426497
- Read time: 1 min
- Topics: ferring pharmaceuticals, gameto, fertilo, ivf, fertility treatments, fertility drugs, reproductive medicine, cell engineering, egg retrieval, ovarian support cells
## Ferring Acquires Gameto
Ferring Pharmaceuticals has agreed to acquire Austin-based biotech company Gameto for $1.4 billion.
## Gameto's Fertilo Technology
Gameto's Fertilo technology matures eggs outside the body, reducing injections from 12 days to three days.
## Fertilo Benefits
Fertilo lowers risks for women with health conditions and reduces side effects from hormone doses.
## Clinical Trials
Gameto's technology is in phase 3 clinical trials but expected to win regulatory approval.
## Dr. Dina Turner's Statement
Dr. Dina Turner, Gameto co-founder and CEO, said combining their cell-engineering platform with Ferring's global reach will accelerate innovation.
## Traditional IVF Process
Traditional IVF requires up to two weeks of self-administered injections to produce multiple mature eggs.
## Fertilo's Advantages
Fertilo yields healthy eggs ready for fertilization and protects patients from systemic hormonal stimulation.
## Fertilo's Effectiveness
Fertilo is less expensive and less risky than traditional IVF but slightly less effective, according to 2020 research.
## What Happens Next
Ferring and Gameto aim to expand access to modern fertility treatments globally by 2027.
## Key takeaway

Ferring Pharmaceuticals acquired Gameto for $1.4 billion to improve fertility treatments through Fertilo technology, reducing injections and risks.